Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5 patients using the Safety Correction of High-dose Antipsychotic Polypharmacy (SCAP) meth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Psychopharmacol Neurosci
Autori principali: Kamei, Hiroyuki, Yamada, Hanae, Hatano, Masakazu, Hanya, Manako, Yamada, Shigeki, Iwata, Nakao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean College of Neuropsychopharmacology 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006980/
https://ncbi.nlm.nih.gov/pubmed/31958917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.159
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi